Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
about
Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.Overcoming platinum resistance in ovarian carcinoma.Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates.Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma.Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.Physicochemical characterization of 9-aminocamptothecin in aqueous solutions.Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies.Semisynthesis, cytotoxic activity, and oral availability of new lipophilic 9-substituted camptothecin derivatives.Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
P2860
Q30444706-0C5BAC29-2019-4623-9AD2-8EAA63A86CA6Q34233273-88580634-4818-42BF-8E7C-9A596F76CA7EQ36444444-CFECF726-6785-4214-9FC2-2824710E20BEQ37159547-17AFFBA1-A2F9-4F22-9A31-1B64CCC4F409Q37212223-46DDB055-558E-4BD1-BE13-15FE8B2CC978Q37538913-D98B367C-1434-4B7B-AE47-7797EF034E89Q38682200-97EEBEED-8961-45A7-9CC7-05F36B3F304AQ39777927-2061EC98-EF4C-4D8F-84EC-9C4A2C9094A8Q47220295-FDB5B704-3DDC-483B-849D-121828DB6E86
P2860
Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase II evaluation of 9-amino ...... ecologic Oncology Group Study.
@ast
Phase II evaluation of 9-amino ...... ecologic Oncology Group Study.
@en
type
label
Phase II evaluation of 9-amino ...... ecologic Oncology Group Study.
@ast
Phase II evaluation of 9-amino ...... ecologic Oncology Group Study.
@en
prefLabel
Phase II evaluation of 9-amino ...... ecologic Oncology Group Study.
@ast
Phase II evaluation of 9-amino ...... ecologic Oncology Group Study.
@en
P2093
P1433
P1476
Phase II evaluation of 9-amino ...... ecologic Oncology Group Study.
@en
P2093
Jeanne Schilder
Jeffrey Bloss
Joel Sorosky
John A Blessing
Russell Schilder
Steven Waggoner
P356
10.1016/J.YGYNO.2004.09.015
P407
P577
2005-01-01T00:00:00Z